Coronavirus COVID19 vaccine update: 23 potential vaccines enter human trials; Check country-wise status

Coronavirus COVID19 vaccine news update today: Russia has claimed that Moscow State Medical University has successfully completed the clinical trials for the world’s first coronavirus vaccine. (Reuters image)

Coronavirus vaccine news, update, Russia, India, USA status today:  Research Institutes and pharma companies around the world have been endeavoring to develop a coronavirus vaccine. So far, there are over 135 potential candidates at the preclinical stage around the world. 15 potential candidates for the COVID19 vaccine are at the Phase I stage. Over 23 potential vaccines for Coronavirus are in the human trials.

While, Russia is leading the race at this moment but the US, the UK, India, China, and Australia have been working on multiple potential candidates for COVID19 vaccine.

Meanwhile, Pharmaceutical companies have ramped up clinical trials in the past month. The research, which was prepared by clinical trial technology company Medidata, shows that the number of new subjects entering trials increased 112 per cent in June compared with the low point in April, as per a Reuters report.

Coronavirus vaccine Russia

Russia has claimed that Moscow State Medical University has successfully completed the clinical trials for the world’s first coronavirus vaccine. Director of the Institute for Translation Medicine and Biotechnology Vadim Tarasov has revealed that the first batch of volunteers will be discharged on July 15 and the second group will be discharged on July 20. Clinical trials of coronavirus vaccine began at the Gamalei Institute of Epidemiology and Microbiology on June 18.

Coronavirus vaccine In India

According to the latest reports, COVAXIN, jointly developed by Bharat Biotech, Indian Council of Medical Research (ICMR), and National Institute of Virology, Pune, has entered the human trials phase. Another potential candidate Zydus Cadila is still at Phase I.

Coronavirus vaccine UK, Oxford, AstraZeneca

In the UK, two potential Coronavirus vaccine candidates have raised hopes. One is developed by the University of Oxford and AstraZeneca is at Phase III. Another is being developed by Imperial College London and its has entered the Phase II stage.

Coronavirus vaccine USA

In the US, a potential COVID19 vaccine developed by Moderna is at the Phase II stage and another vaccine Novavax is at the Phase II stage.

Coronavirus Vaccine China

In China, there are four potential coronavirus vaccine candidates that are at different stages of development. Wuhan Institute and Sinopharm’s COVID19 vaccine candidate is at the Phase II stage. Sinovac and Instituto Butantan are developing one which is at the Phase III stage. CanSino Biological Inc. and Beijing Institue of Biotech’s potential coronavirus candidate has been approved for military use. Beijing Institute of Biological products and Sinopharm’s vaccine candidate is at the Phase II stage.

In Germany, BioNTech, Pfizer, and Fosun Pharma’s potential vaccine candidate has managed to reach the Phase II stage of development.

In Australia, Vaxine Pty Ltd and Medytox’s potential vaccine candidate is at Phase I stage.